Sai Life Sciences’ unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s upper limit of Rs 549.
ETMarkets Smart Talk | 2H2025 market returns may moderate, but India’s long-term story intact: Abhiram Eleswarapu
India outperformed considerably in 2024 which partly explains part of the underperformance this year. By around September last year, valuations were no longer inexpensive, earnings